Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intensity Therapeutics, Inc.

0.3250
0.0000
Post-market: 0.32990.0049+1.51%19:57 EDT
Volume:6.18M
Turnover:2.04M
Market Cap:8.15M
PE:-0.31
High:0.3382
Open:0.3300
Low:0.3193
Close:0.3250
Loading ...
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Nov 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 05, 2023

Major Issues Report

Form 8-K - Current report
Aug 23, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jul 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 29, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 27, 2023

Correspondence

Form CORRESP - Correspondence
Jun 27, 2023

Correspondence

Form CORRESP - Correspondence
Jun 23, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 23, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 10, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 09, 2023

Correspondence

Form CORRESP - Correspondence
Jun 01, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses